JAPAY
Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, prescription drugs, and processed foods in Japan and internationally. The company operates through four segments: Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. It offers tobacco products, such as cigarettes, cigars, pipe tobacco, oral tobacco, waterpipe tobacco, kretek, and fine cut products under the Winston, Camel, MEVIUS, and LD brands. The company also provides reduced-risk products, including tobacco-infused vapor and heated tobacco products, E-Vapor products, etc. under the Ploom, Logic, Ploom TECH, Ploom TECH+, and Ploom S brands. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, renal and metabolism, immunology, and neuroscience. Further, the company provides staple food products, such as frozen noodles and okonomiyaki, and frozen and packed cooked rice; ambient processed foods; bakery products; and seasonings, including yeast extracts and oyster sauce. Japan Tobacco Inc. was founded in 1898 and is headquartered in Tokyo, Japan.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | 55.93 | $940.9B | $15.8B |
| 2025 Q4 | -0.45 | $848.7B | $186.7B |
| 2025 Q3 | 55.00 | $915.2B | $80.7B |
| 2025 Q2 | 45.75 | $907.6B | $148.6B |
| 2025 Q1 | 44.35 | $827.0B | -$34.1B |
| 2024 Q4 | -74.11 | $756.5B | $196.4B |
| 2024 Q3 | 38.65 | $823.4B | $102.0B |
| 2024 Q2 | 41.65 | $829.6B | $164.4B |